Nuss John — SEC Form 4 filings
SEC reporting owner CIK 1874108. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-29 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 50,493 shares, $188,303 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 12,675 shares @ $7.72 ($97,840) in Ventyx Biosciences, Inc., filed 2025-12-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) | CHIEF SCIENTIFIC OFFICER | 10 | — | 5 legs · 50,493 sh · $188,303 | 23 |
Form 4 filings — Nuss John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 489,481 · Disposition to issuer (D): 9,063 (derivative) · Disposition to issuer (D): 415,104 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 181,250 (derivative) · Disposition to issuer (D): 192,778 (derivative) · +3 more | EDGAR |
| 2025-12-19 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 34,930 @ $0 · Sale (S): 12,675 @ $7.72 · Option exercise (M): 34,930 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Sale (S): 1,887 @ $1.07 | EDGAR |
| 2025-04-01 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 4,531 @ $0 · Option exercise (M): 4,531 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 245,000 (derivative) @ $0 · Grant/award (A): 170,104 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Ventyx Biosciences, Inc. (VTYX) | Sale (S): 21,119 @ $2.36 | EDGAR |
| 2024-12-19 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 34,930 @ $0 · Sale (S): 13,161 @ $2.26 · Option exercise (M): 34,930 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 5,377 @ $0.20 · Option exercise (M): 193,557 @ $0.20 · Option exercise (M): 5,377 (derivative) @ $0 · Option exercise (M): 193,557 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Sale (S): 1,651 @ $5.40 | EDGAR |
| 2024-03-29 | 4 | Ventyx Biosciences, Inc. (VTYX) | Option exercise (M): 4,531 @ $0 · Option exercise (M): 4,531 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1874108 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →